TLDR:
- Datavault AI stock soars 28% after $150M investment deal with Scilex Holding!
- Datavault AI secures $150M from Scilex to advance supercomputing and AI-driven growth.
- Datavault AI’s stock jumps 28% with $150M investment to boost infrastructure.
- Scilex invests $150M in Datavault AI for biotech and AI-driven data growth.
- Datavault AI secures $150M from Scilex to lead supercomputing, data trading markets.
Datavault AI Inc. (DVLT) experienced a remarkable surge on September 25, 2025, rising by 28.43% to $0.8348 by market close. The stock continued its upward momentum in after-hours trading, climbing to $1.0100, an additional 20.99% gain.
This sharp increase follows the announcement of a strategic $150 million investment deal with Scilex Holding Company (SCLX), which promises to enhance Datavault AI’s infrastructure and market position.
Datavault AI Secures $150M Strategic Investment
The investment will be made in two tranches, with the first tranche of $8.067 million set to close on September 26, 2025. The remaining $141.933 million will close following shareholder approval. This investment is structured through a purchase agreement executed in Bitcoin (BTC), with the exchange rate provided by Coinbase.com at the time. This capital infusion will strengthen its balance sheet and accelerate growth initiatives.
The funds will specifically be allocated to advancing Datavault’s supercomputing infrastructure and expanding its data exchange platforms. The partnership is expected to unlock new revenue streams by leveraging AI-driven data visualization and blockchain-secured data trading. The company aims to position itself as a leader in markets requiring high-performance computing.
Scilex’s Role in the Investment and Future Outlook
Henry Ji, CEO of Scilex Holding Company, emphasized the potential for this partnership in transforming biotech markets. He noted that Datavault AI’s technologies align perfectly with the sector’s needs for advanced data analytics and supercomputing power. Ji further explained that Scilex’s resources would help maximize Datavault’s revenue generation, particularly in biotech.
Datavault AI’s CEO, Nathaniel Bradley, echoed these sentiments, stating that the investment would enable the company to expand its technology platforms. He highlighted the collaboration with the U.S. Department of Energy’s Brookhaven National Laboratory and IBM WatsonX, which is set to enhance its high-performance computing capabilities. Bradley also pointed to the company’s initiatives in leveraging Web 3.0 technologies, such as blockchain-secured data trading and AI-driven analytics.
Transaction Details and Stockholder Approval
The deal includes a provision where Scilex Holding will receive an aggregate of 278,914,094 shares of Datavault AI, priced at $0.5378 per share. 15 million shares will be issued following the first tranche, with the remainder to be issued in the second tranche in the form of a pre-funded warrant. The completion of the second tranche is unpredictable upon shareholder approval for issuing shares beyond the 19.99% share limitation under Nasdaq rules.
Scilex will also gain rights to nominate two directors to Datavault’s board, as long as its beneficial ownership remains at 10% or more. Should Scilex’s ownership fall between 5% and 10%, it will retain the right to nominate one director.
The securities offered in this transaction are covered under a shelf registration statement filed with the SEC earlier in July 2025. The company plans to seek stockholder approval at its annual meeting to finalize the second tranche.
